Cumberland Pharmaceuticals CPIX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's change in AP?
- Cumberland Pharmaceuticals (CPIX) reported change in AP of -$1.35M in Q1 2026.
- How has Cumberland Pharmaceuticals's change in AP changed year-over-year?
- Cumberland Pharmaceuticals's change in AP decreased by 124.3% year-over-year, from -$600.04K to -$1.35M.
- What is the long-term trend for Cumberland Pharmaceuticals's change in AP?
- Over 3 years (2021 to 2025), Cumberland Pharmaceuticals's change in AP has grown at a 106.9% compound annual growth rate (CAGR), from -$757.59K to $6.71M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.